3-nitropropionic acid has been researched along with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (19.05) | 18.2507 |
| 2000's | 14 (66.67) | 29.6817 |
| 2010's | 3 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brouillet, E; Hantraye, P | 1 |
| Albertson, C; Schmued, LC; Slikker, W | 1 |
| Beal, MF; Dichgans, J; Klockgether, T; Matthews, RT; Schulz, JB | 1 |
| Cheng, FC; Dryhurst, G; Han, J; Yang, Z | 1 |
| Andersen, JK; Andreassen, OA; Beal, MF; Bogdanov, M; Dedeoglu, A; Ferrante, RJ; Jiang, D; Klivenyi, P; Lancelot, E; Mueller, G | 1 |
| Aubert, I; Bezard, E; Fernagut, PO; Ghorayeb, I; Poewe, W; Tison, F; Wenning, GK | 1 |
| Albers, DW; Andreassen, OA; Beal, MF; Carlson, EJ; Dedeoglu, A; Epstein, CJ; Ferrante, RJ; Klivenyi, P | 1 |
| Albers, DS; Andreassen, OA; Beal, MF; Dedeoglu, A; Ferrante, RJ; Klein, AM; Klivenyi, P; Kowall, NW | 1 |
| Endo, K; Kayama, H; Nakahara, T; Yamamoto, T | 1 |
| Bioulac, B; Fernagut, PO; Ghorayeb, I; Stefanova, N; Tison, F; Wenning, GK | 1 |
| Brouillet, E; Fernagut, PO; Jellinger, KA; Poewe, W; Puschban, Z; Reindl, M; Stefanova, N; Tison, F; Wenning, GK | 1 |
| Bioulac, B; Diguet, E; Fernagut, PO; Tison, F | 1 |
| Beal, MF; Browne, SE; Bubber, P; Calingasan, NY; Gardian, G; Gibson, GE; Klivenyi, P; Patel, MS; Starkov, AA; Yang, L | 1 |
| Beal, MF; Bizat, N; Brouillet, E; Joh, TH; Kiaei, M; Mischak, RP; Sugama, S; Yang, L | 1 |
| Beal, MF; Calingasan, NY; Chen, J; Cleren, C | 1 |
| Hartai, Z; Juhasz, G; Kekesi, KA; Klivenyi, P; Vecsei, L | 1 |
| Diaz-Muñoz, M; Garcia, E; Giordano, M; Herrera-Mundo, MN; Limon, D; Maldonado, PD; Pedraza-Chaverri, J; Perez-De La Cruz, V; Santamaria, A | 1 |
| Beal, MF; Calingasan, NY; Cormier, K; Ferrante, RJ; Smith, K; Wille, EJ; Yang, L | 1 |
| Beal, MF | 1 |
| Chaudhary, RK; Deshmukh, RS; Roy, I | 1 |
| Cai, AL; Sheline, CT; Shi, C; Zhang, W; Zhu, J | 1 |
3 review(s) available for 3-nitropropionic acid and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
| Article | Year |
|---|---|
Effects of chronic MPTP and 3-nitropropionic acid in nonhuman primates.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antihypertensive Agents; Disease Models, Animal; Energy Metabolism; Huntington Disease; Nitro Compounds; Parkinson Disease; Propionates | 1995 |
The role of mitochondrial dysfunction and neuronal nitric oxide in animal models of neurodegenerative diseases.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Disease Models, Animal; Dopamine Agents; Hydroxyl Radical; Mice; Mitochondria; Neurodegenerative Diseases; Nitric Oxide; Nitro Compounds; Primates; Propionates; Rats | 1997 |
Neuroprotective effects of creatine.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Creatine; Humans; Neurodegenerative Diseases; Neuroprotective Agents; Nitro Compounds; Propionates | 2011 |
18 other study(ies) available for 3-nitropropionic acid and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
| Article | Year |
|---|---|
Fluoro-Jade: a novel fluorochrome for the sensitive and reliable histochemical localization of neuronal degeneration.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antihypertensive Agents; Axons; Dizocilpine Maleate; Dopamine Agents; Eosine Yellowish-(YS); Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Eye Enucleation; Fluorescent Antibody Technique; Fluorescent Dyes; Hallucinogens; Hematoxylin; Ibogaine; Kainic Acid; Male; Metals; Nerve Degeneration; Nissl Bodies; Nitro Compounds; Phencyclidine; Propionates; Rats; Rats, Sprague-Dawley; Sensitivity and Specificity; Silver Staining; Stereotaxic Techniques | 1997 |
Inhibitors of mitochondrial respiration, iron (II), and hydroxyl radical evoke release and extracellular hydrolysis of glutathione in rat striatum and substantia nigra: potential implications to Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Animals; Corpus Striatum; Cysteine; Glutamic Acid; Glutathione; Glycine; Hydrolysis; Hydroxyl Radical; Iron; Kinetics; Male; Microdialysis; Mitochondria; Models, Chemical; Nitro Compounds; Oxygen Consumption; Parkinson Disease; Perfusion; Propionates; Rats; Rats, Sprague-Dawley; Substantia Nigra | 1999 |
Mice deficient in cellular glutathione peroxidase show increased vulnerability to malonate, 3-nitropropionic acid, and 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Brain Chemistry; Catechols; Convulsants; Corpus Striatum; Disease Models, Animal; Dopamine Agents; Female; Free Radicals; Glutathione; Glutathione Peroxidase; Heterozygote; Homovanillic Acid; Homozygote; Huntington Disease; Male; Malonates; Mice; Mice, Inbred Strains; Mice, Knockout; MPTP Poisoning; Nitro Compounds; Oxidative Stress; Parkinson Disease, Secondary; Propionates; Tyrosine | 2000 |
Toward a primate model of L-dopa-unresponsive parkinsonism mimicking striatonigral degeneration.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antiparkinson Agents; Brain Mapping; Corpus Striatum; Diagnosis, Differential; Disease Models, Animal; Dopamine; Levodopa; Macaca fascicularis; Male; Multiple System Atrophy; Nerve Degeneration; Neurotoxins; Nitro Compounds; Parkinson Disease, Secondary; Propionates; Striatonigral Degeneration | 2000 |
Mice with a partial deficiency of manganese superoxide dismutase show increased vulnerability to the mitochondrial toxins malonate, 3-nitropropionic acid, and MPTP.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Carrier Proteins; Corpus Striatum; Disease Models, Animal; Dopamine; Dopamine Plasma Membrane Transport Proteins; Female; Genetic Predisposition to Disease; Gentisates; Heterozygote; Homovanillic Acid; Hydroxybenzoates; Hydroxyl Radical; Male; Malonates; Membrane Glycoproteins; Membrane Transport Proteins; Mice; Mice, Knockout; Mitochondria; Nerve Tissue Proteins; Neurodegenerative Diseases; Neurotoxins; Nitro Compounds; Propionates; Salicylic Acid; Superoxide Dismutase | 2001 |
Transgenic ALS mice show increased vulnerability to the mitochondrial toxins MPTP and 3-nitropropionic acid.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Amyotrophic Lateral Sclerosis; Animals; Convulsants; Corpus Striatum; Dopamine; Dopamine Agents; Female; Hazardous Substances; Homovanillic Acid; Male; Mice; Mice, Transgenic; Mitochondria; Nitro Compounds; Propionates; Superoxide Dismutase | 2001 |
Neuronal ectopic expression of tyrosine hydroxylase in the mouse striatum by combined administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 3-nitropropionic acid.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Aromatic-L-Amino-Acid Decarboxylases; Convulsants; Corpus Striatum; Cytoplasm; Dopamine Agents; Endoplasmic Reticulum; Gene Expression Regulation, Enzymologic; Immunohistochemistry; Male; Mice; Mice, Inbred C57BL; Microscopy, Immunoelectron; Neurons; Nitro Compounds; Parkinsonian Disorders; Propionates; RNA, Messenger; Tyrosine 3-Monooxygenase | 2001 |
Dystonia is predictive of subsequent altered dopaminergic responsiveness in a chronic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine+3-nitropropionic acid model of striatonigral degeneration in monkeys.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antiparkinson Agents; Corpus Striatum; Disease Models, Animal; Dopamine; Dopamine Agents; Dystonia; Female; Levodopa; Macaca fascicularis; Neurotoxins; Nitro Compounds; Parkinsonian Disorders; Propionates; Putamen; Striatonigral Degeneration; Substantia Nigra | 2002 |
Neuropathological and behavioral changes induced by various treatment paradigms with MPTP and 3-nitropropionic acid in mice: towards a model of striatonigral degeneration (multiple system atrophy).
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Behavior, Animal; Brain; Disease Models, Animal; Dopamine Agents; Drug Interactions; Male; Mice; Mice, Inbred C57BL; Neurotoxins; Nitro Compounds; Propionates; Striatonigral Degeneration; Tyrosine 3-Monooxygenase | 2003 |
MPTP potentiates 3-nitropropionic acid-induced striatal damage in mice: reference to striatonigral degeneration.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Behavior, Animal; Cell Count; Corpus Striatum; Disease Models, Animal; Disease Progression; Drug Synergism; Male; Mice; Mice, Inbred C57BL; Motor Activity; Neurons; Nitro Compounds; Propionates; Reproducibility of Results; Striatonigral Degeneration; Survival Rate | 2004 |
Mice deficient in dihydrolipoamide dehydrogenase show increased vulnerability to MPTP, malonate and 3-nitropropionic acid neurotoxicity.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Caudate Nucleus; Cell Count; Cerebral Cortex; Corpus Striatum; Dihydrolipoamide Dehydrogenase; Disease Models, Animal; Genetic Predisposition to Disease; Heterozygote; Huntington Disease; Ketoglutarate Dehydrogenase Complex; Malonates; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitochondria; Neurodegenerative Diseases; Neurons; Nitro Compounds; Parkinsonian Disorders; Propionates; Putamen; Pyruvate Dehydrogenase Complex; Substantia Nigra | 2004 |
A novel systemically active caspase inhibitor attenuates the toxicities of MPTP, malonate, and 3NP in vivo.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Amino Acid Chloromethyl Ketones; Animals; BH3 Interacting Domain Death Agonist Protein; Brain; Calpain; Carrier Proteins; Caspase 8; Caspase 9; Caspase Inhibitors; Caspases; Corpus Striatum; Dopamine Agents; Enzyme Inhibitors; Male; Malonates; Mesencephalon; Mice; Neurotoxins; Nitro Compounds; Propionates; Quinolines; Rats; Rats, Inbred Lew; Rats, Sprague-Dawley | 2004 |
Celastrol protects against MPTP- and 3-nitropropionic acid-induced neurotoxicity.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Anti-Inflammatory Agents; Antioxidants; Cell Nucleus; Cytoplasm; Dopamine; Dopamine Antagonists; Gliosis; HSP70 Heat-Shock Proteins; Male; Mice; MPTP Poisoning; Neurons; Neuroprotective Agents; Neurotoxins; Nitro Compounds; Pentacyclic Triterpenes; Propionates; Rats; Rats, Inbred Lew; Substantia Nigra; Triterpenes | 2005 |
Effects of mitochondrial toxins on the brain amino acid concentrations.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Amino Acids; Animals; Brain Chemistry; Cerebral Cortex; Huntington Disease; Male; Mice; Mitochondria; Neurotoxins; Nitro Compounds; Parkinson Disease; Propionates | 2005 |
Lipid peroxidation, mitochondrial dysfunction and neurochemical and behavioural deficits in different neurotoxic models: protective role of S-allylcysteine.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antioxidants; Basal Ganglia; Behavior, Animal; Biomarkers; Cysteine; Disease Models, Animal; Dopamine; Lipid Peroxidation; Male; Mice; Mice, Inbred C57BL; Mitochondria; Motor Activity; MPTP Poisoning; Neuroprotective Agents; Neurotoxicity Syndromes; Nitro Compounds; Oxidative Stress; Oxidopamine; Propionates; Rats; Rats, Wistar; Synaptosomes; Time Factors | 2008 |
Combination therapy with coenzyme Q10 and creatine produces additive neuroprotective effects in models of Parkinson's and Huntington's diseases.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 8-Hydroxy-2'-Deoxyguanosine; alpha-Synuclein; Analysis of Variance; Animals; Chromatography, High Pressure Liquid; Creatine; Deoxyguanosine; Disease Models, Animal; Dopamine; Drug Therapy, Combination; Glutathione; Glutathione Disulfide; Huntington Disease; Lipid Peroxidation; Male; Malondialdehyde; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Nitro Compounds; Parkinson Disease; Propionates; Rats; Rats, Inbred Lew; Tyrosine 3-Monooxygenase; Ubiquinone | 2009 |
Effect of pesticides on the aggregation of mutant huntingtin protein.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Electrophoresis, Polyacrylamide Gel; Mutant Proteins; Nerve Tissue Proteins; Nitro Compounds; Pesticides; Propionates; Protein Structure, Quaternary; Rotenone | 2012 |
Mitochondrial inhibitor models of Huntington's disease and Parkinson's disease induce zinc accumulation and are attenuated by inhibition of zinc neurotoxicity in vitro or in vivo.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Carrier Proteins; Cation Transport Proteins; Cell Death; Cells, Cultured; Cerebral Cortex; Dihydroxyacetone Phosphate; Disease Models, Animal; Drug Interactions; Embryo, Mammalian; Fructose-Bisphosphatase; Humans; Huntington Disease; Male; Matrix Metalloproteinase 16; Membrane Proteins; Membrane Transport Proteins; Mental Disorders; Mice; Mice, Inbred C57BL; Mice, Neurologic Mutants; Mice, Transgenic; NAD; Neurons; Niacinamide; Nitro Compounds; Oxidopamine; Parkinson Disease; Propionates; Pyruvic Acid; Rats; Rats, Long-Evans; Tyrosine 3-Monooxygenase; Zinc | 2013 |